Dr. Clark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8910 Purdue Road
Suite 250
Indianapolis, IN 46268Phone+1 317-876-1478- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1995 - 1998
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1994 - 1994
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1991 - 1994
- Indiana University School of MedicineClass of 1991
Certifications & Licensure
- IN State Medical License 1999 - 2017
Clinical Trials
- Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer Start of enrollment: 2006 Sep 01
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
- A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsPhase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular CarcinomaSafi Shahda, Patrick J. Loehrer, Romnee Clark, A. John Spittler, Sandra K. Althouse, E. Gabriella Chiorean> ;The Oncologist. 2016 Jun 1
- 24 citationsPhase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer.E. Gabriela Chiorean, Bryan P. Schneider, Fatih Akisik, Susan M. Perkins, Stephen C. Anderson, Cynthia S. Johnson, John M. DeWitt, Paul R. Helft, Romnee Clark, Erica L...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Jun 1
- 16 citationsPhase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal ca...E. Gabriela Chiorean, Sonal P. Sanghani, Marissa A. Schiel, Menggang Yu, Matthew Burns, Yan Tong, David T. Hinkle, Nicki Coleman, Bruce W. Robb, Julia K. Leblanc, Romn...> ;Cancer Chemotherapy and Pharmacology. 2012 May 18
- Join now to see all
Hospital Affiliations
- Eskenazi HealthIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: